Anika Therapeutics appointed Susan Vogt to its board of directors.
Biologics
Degenerative disc disease patients who received intradiscal injections of SpinalCyte's CybroCell showed sustained pain relief improvement and greater back mobility after 12 months, according to the results of a phase 1/2 clinical trial.
Regentis Biomaterials expanded its clinical trial of GelrinC for the treatment of articular knee cartilage damage to 11 U.S. sites.
BoneSupport launched its own U.S. distributor network.
Three Los Angeles-based Cedars-Sinai investigators developed a method to harness stem cells to regrow tissue damaged by major trauma. The Department of Defense and National Institutes of Health awarded the researchers $8 million in grants.
Advertisement
Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.
Vertebral body mesenchymal stem cells derived from whole bone marrow aspirate may provide alternative stem cell sources for spine surgery applications, according to a study in Spine.
LifeNet Health launched the PliaFX Prime allograft surgical solution.
Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).